Literature DB >> 10561219

EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.

J P Ginsberg1, E de Alava, M Ladanyi, L H Wexler, H Kovar, M Paulussen, A Zoubek, B Dockhorn-Dworniczak, H Juergens, J S Wunder, I L Andrulis, R Malik, P H Sorensen, R B Womer, F G Barr.   

Abstract

PURPOSE: There are a variety of solid tumors in which alternative chromosomal translocations generate related fusion products. In alveolar rhabdomyosarcoma and synovial sarcoma, these variant fusions have been found to have major clinical significance. We investigated whether the two alternative gene fusion products, EWS-FLI1 and EWS-ERG, define different clinical subsets within the Ewing's sarcoma family of tumors. PATIENTS AND METHODS: We selected 30 cases of Ewing's sarcoma with the EWS-ERG gene fusion and 106 cases with the EWS-FLI1 fusion. Clinical data were obtained for each case and compared with the molecular diagnostic findings.
RESULTS: There were no significant clinical differences observed between the two groups in age of diagnosis, sex, metastasis at diagnosis, primary site, event-free survival, or overall survival.
CONCLUSION: Differences in the C-terminal partner in the Ewing's sarcoma family gene fusions are not associated with significant phenotypic differences.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10561219     DOI: 10.1200/JCO.1999.17.6.1809

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  53 in total

1.  PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins.

Authors:  Benjamin Deneen; Scott M Welford; Thu Ho; Felicia Hernandez; Irwin Kurland; Christopher T Denny
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

2.  Ewing sarcoma with ERG gene rearrangements: A molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH.

Authors:  Sonja Chen; Kemal Deniz; Yun-Shao Sung; Lei Zhang; Sarah Dry; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2015-12-22       Impact factor: 5.006

3.  Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.

Authors:  E de Alava; A Panizo; C R Antonescu; A G Huvos; F J Pardo-Mindán; F G Barr; M Ladanyi
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Molecular diagnosis of ewing family tumors: too many fusions... ?

Authors:  Frederic G Barr; Richard B Womer
Journal:  J Mol Diagn       Date:  2007-07-25       Impact factor: 5.568

Review 5.  Role of ancillary techniques in profiling unclassified laryngeal malignancies.

Authors:  H Hellquist; J L Hunt; A Cardesa; A Skalova; P J Slootweg; A Rinaldo; A Ferlito
Journal:  Virchows Arch       Date:  2018-04-06       Impact factor: 4.064

6.  Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage.

Authors:  Elizabeth A Kruse; Stephen J Loughran; Tracey M Baldwin; Emma C Josefsson; Sarah Ellis; Dennis K Watson; Paquita Nurden; Donald Metcalf; Douglas J Hilton; Warren S Alexander; Benjamin T Kile
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-31       Impact factor: 11.205

7.  ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.

Authors:  Markku Miettinen; Zeng-Feng Wang; Anders Paetau; Shyh-Han Tan; Albert Dobi; Shiv Srivastava; Isabell Sesterhenn
Journal:  Am J Surg Pathol       Date:  2011-03       Impact factor: 6.394

8.  Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.

Authors:  Ying Xie; Mia Lee Koch; Xin Zhang; Melanie J Hamblen; Frank J Godinho; Yuko Fujiwara; Huafeng Xie; Jan-Henning Klusmann; Stuart H Orkin; Zhe Li
Journal:  Stem Cells       Date:  2017-04-24       Impact factor: 6.277

9.  Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors.

Authors:  Barbara Patócs; Krisztina Németh; Miklós Garami; Gabriella Arató; Ilona Kovalszky; Miklós Szendrői; György Fekete
Journal:  Cell Oncol (Dordr)       Date:  2013-03-14       Impact factor: 6.730

Review 10.  Emerging chemotherapeutic strategies and the role of treatment stratification in Ewing sarcoma.

Authors:  Beatrice M Seddon; Jeremy S Whelan
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.